α7 Nicotinic Acetylcholine Receptor Mediates the Neuroprotection of Remote Ischemic Postconditioning in a Rat Model of Asphyxial Cardiac Arrest

J Surg Res. 2020 Feb:246:6-18. doi: 10.1016/j.jss.2019.07.091. Epub 2019 Sep 18.

Abstract

Background: Remote ischemic postconditioning (RIPost) has been shown to reduce the ischemia-reperfusion injury of the heart and brain. However, the protection mechanisms have not yet been fully elucidated. We have observed that RIPost could alleviate the brain injury after cardiac arrest (CA). The aim of this study was to explore whether α7 nicotinic acetylcholine receptor (α7nAChR) mediates the neuroprotection of RIPost in a rat model of asphyxial CA.

Materials and methods: Asphyxial CA model was induced by occlusion of the tracheal tube for 8 min and resuscitated later. RIPost produced by three cycles of 15-min occlusion and 15-min release of the right hind limb by a tourniquet was performed respectively at the moment and the third hour after restoration of spontaneous circulation. The α7nAChR agonist PHA-543613 and the antagonist methyllycaconitine (MLA) were used to investigate the role of α7nAChR in mediating neuroprotective effects.

Results: Results showed that α7nAChR was decreased in hippocampus and cortex after resuscitation, whereas RIPost could attenuate the reduction. The use of PHA-543613 provided neuroprotective effects against cerebral injury after CA. Furthermore, RIPost decreased the levels of neuron-specific enolase, inflammatory mediators, the number of apoptotic cells, and phosphorylation of nuclear factor-κB while increased the phosphorylation of signal transducer and activator of transcription-3. However, the above effects of RIPost were attenuated by α7nAChR antagonist methyllycaconitine.

Conclusions: Neuroprotection of RIPost was related with the activation of α7nAChR, which could suppress nuclear factor-κB and activate signal transducer and activator of transcription-3 in a rat asphyxial CA model.

Keywords: Brain; Cardiac arrest; Inflammation; Remote ischemic postconditioning; α7 nicotinic acetylcholine receptor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aconitine / analogs & derivatives
  • Aconitine / pharmacology
  • Animals
  • Asphyxia / complications
  • Bridged Bicyclo Compounds, Heterocyclic / pharmacology
  • Disease Models, Animal
  • Heart Arrest / etiology
  • Heart Arrest / therapy*
  • Hippocampus / blood supply
  • Hippocampus / pathology
  • Humans
  • Hypoxia, Brain / etiology
  • Hypoxia, Brain / pathology
  • Hypoxia, Brain / therapy*
  • Ischemic Postconditioning*
  • Male
  • NF-kappa B / metabolism
  • Neuroprotection / drug effects
  • Neuroprotection / physiology*
  • Quinuclidines / pharmacology
  • Rats
  • STAT3 Transcription Factor / metabolism
  • Signal Transduction / drug effects
  • Signal Transduction / physiology
  • Treatment Outcome
  • alpha7 Nicotinic Acetylcholine Receptor / agonists
  • alpha7 Nicotinic Acetylcholine Receptor / antagonists & inhibitors
  • alpha7 Nicotinic Acetylcholine Receptor / metabolism*

Substances

  • Bridged Bicyclo Compounds, Heterocyclic
  • Chrna7 protein, rat
  • N-(1-azabicyclo(2.2.2)oct-3-yl)furo(2,3-c)pyridine-5-carboxamide
  • NF-kappa B
  • Quinuclidines
  • STAT3 Transcription Factor
  • Stat3 protein, rat
  • alpha7 Nicotinic Acetylcholine Receptor
  • methyllycaconitine
  • Aconitine